Veenstra, David L <br/><br/>
Cost-effectiveness of peginterferon alpha-2a compared with lamivudine treatment in patients with HBe-antigen-positive chronic hepatitis B in the United Kingdom.  [electronic resource] 

 -  European journal of gastroenterology & hepatology  Aug 2007 
 - 631-8 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0954-691X 
<br/><br/><label>Standard No.: </label>10.1097/MEG.0b013e3281108079  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiviral Agents--administration & dosage<br/>Cost-Benefit Analysis<br/>Drug Administration Schedule<br/>Drug Costs--statistics & numerical data<br/>Health Care Costs--statistics & numerical data<br/>Hepatitis B e Antigens--blood<br/>Hepatitis B, Chronic--drug therapy<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--administration & dosage<br/>Lamivudine--administration & dosage<br/>Markov Chains<br/>Models, Econometric<br/>Polyethylene Glycols--administration & dosage<br/>Quality of Life<br/>Recombinant Proteins<br/>Sensitivity and Specificity<br/>United Kingdom